Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Acute transverse myelitis after allogeneic bone marrow transplantation for acute lymphoblastic leukemia--a case report].
Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis.
The Regulation of Reactive Changes Around Multiple Sclerosis Lesions by Phosphorylated Signal Transducer and Activator of Transcription.
The incidence and prevalence of multiple sclerosis in nova scotia, Canada.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis.
Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci.
Corneal Sensitivity and Tear Function in Neurodegenerative Diseases.
Mitochondrial complex I gene variations; as a potential genetic risk factor in pathogenesis of multiple sclerosis.
Gilenya Safety Update
Alemtuzumab for multiple sclerosis.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Longitudinal Change in Physical Activity and Its Correlates in Relapsing-Remitting Multiple Sclerosis.
Regional Heterogeneity of Cuprizone-Induced Demyelination: Topographical Aspects of the Midline of the Corpus Callosum.
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.
Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis.
Adaptive voxel, texture and temporal conditional random fields for detection of Gad-enhancing multiple sclerosis lesions in brain MRI.
MOG-IgG in neuromyelitis optica.
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
Optimizing therapy early in multiple sclerosis: An evidence-based view.
[Changes of epidemiological and clinical features and disease concept in multiple sclerosis].
Multiple sclerosis and infections.
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis.
Pages
« first
‹ previous
…
332
333
334
335
336
337
338
339
340
…
next ›
last »